Dalbavancin or oritavancin for skin infections.
Publication
, Journal Article
Corey, GR; Jiang, H; Moeck, G
Published in: N Engl J Med
September 18, 2014
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
September 18, 2014
Volume
371
Issue
12
Start / End Page
1162 / 1163
Location
United States
Related Subject Headings
- Vancomycin
- Teicoplanin
- Skin Diseases, Bacterial
- Male
- Humans
- Glycopeptides
- General & Internal Medicine
- Female
- Anti-Bacterial Agents
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Corey, G. R., Jiang, H., & Moeck, G. (2014). Dalbavancin or oritavancin for skin infections. N Engl J Med, 371(12), 1162–1163. https://doi.org/10.1056/NEJMc1407925
Corey, G Ralph, Hai Jiang, and Greg Moeck. “Dalbavancin or oritavancin for skin infections.” N Engl J Med 371, no. 12 (September 18, 2014): 1162–63. https://doi.org/10.1056/NEJMc1407925.
Corey GR, Jiang H, Moeck G. Dalbavancin or oritavancin for skin infections. N Engl J Med. 2014 Sep 18;371(12):1162–3.
Corey, G. Ralph, et al. “Dalbavancin or oritavancin for skin infections.” N Engl J Med, vol. 371, no. 12, Sept. 2014, pp. 1162–63. Pubmed, doi:10.1056/NEJMc1407925.
Corey GR, Jiang H, Moeck G. Dalbavancin or oritavancin for skin infections. N Engl J Med. 2014 Sep 18;371(12):1162–1163.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
September 18, 2014
Volume
371
Issue
12
Start / End Page
1162 / 1163
Location
United States
Related Subject Headings
- Vancomycin
- Teicoplanin
- Skin Diseases, Bacterial
- Male
- Humans
- Glycopeptides
- General & Internal Medicine
- Female
- Anti-Bacterial Agents
- 42 Health sciences